Avisa Pharma developing 10-minute tuberculosis breath test
Avisa Pharma is focusing primarily on tuberculosis detection, with aims to develop a rapid, point-of-care test that could determine if a patient has the disease within 10 minutes.
Avisa Pharma is focusing primarily on tuberculosis detection, with aims to develop a rapid, point-of-care test that could determine if a patient has the disease within 10 minutes.
Louisville startup Breath Diagnostics has developed technology to pick up cancer-related compounds that are exhaled in one's breath.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.